Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity

Journal of Clinical Investigation

Volumn 106, Issue 6, 2000, Pages

  Shustov, Andrei ^a   Luzina, Irina ^a   Nguyen, Phuong ^a   Papadimitriou, John C ^b   Handwerger, Barry ^a   Elkon, Keith B ^c   Via, Charles S ^a,b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; PERFORIN;

ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033805162     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8876     Document Type: Article

References (39)

1. Rouvier, E., Luciani, M.F., and Golstein, P. 1993. Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200.
2. Millard, P.J., Henkart, M.P., Reynolds, C.W., and Henkart, P.A. 1984. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J. Immunol. 132:3197-3204.
3. Clark, W.R., et al. 1995. Molecular pathways of CTL-mediated cytotoxicity. Immunol. Rev. 146:33-44.
4. Kagi, D., et al. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:31-37.
5. van den Broek, M.E., et al. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
6. Cohen, P.L., and Eisenberg, R.A. 1992. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today. 13:427-428.
7. Topham, D.J., Tripp, R.A., and Doherty, P.C. 1997. CDS+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159:5197-5200.
8. Peng, S.L., Moslehi, J., Robert, M.E., and Craft, J.E. 1998. Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160:652-660.
9. Gleichmann, E., Pals, S.T., Rolink, A.G., Radaszkiewicz, T., and Gleichmann, H. 1984. Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases. Immunol. Today. 5:324-332.
10. Shustov, A., Nguyen, P., Finkelman, F.D., Elkon, K.B., and Via, C.S. 1998. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production. J. Immunol. 161:2848-2855.
11. Hakim, F.T., Sharrow, S.O., Payne, S., and Shearer, G.M. 1991. Repopulation of host lymphohematopoietic systems by donor cells during graft-versus-host reaction in unirradiated adult F1 mice injected with parental lymphocytes. J. Immunol. 146:2108-2115.
12. Via, C.S., and Finkelman, F.D. 1993. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5:565-572.
13. Rus, V., Svetic, A., Nguyen, P., Gause, W.C., and Via, C.S. 1995. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine grafr-versus-host disease. Regulatory role of donor CD8+ T cells. J. Immunol. 155:2396-2406.
14. Via, C.S., Sharrow, S.O., and Shearer, G.M. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139:1840-1849.
15. Svetic, A., et al. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147:2391-2397.
16. Handwerger, B.S., Storrer, C.E., Wasson, C.S., Movafagh, F., and Reichlin, M. 1999. Further characterization of the autoantibody response of Palmerston North mice. J. Clin. Immunol. 19:45-57.
17. Luzina, I.G., et al. 1999. Vasculitis in the Palmerston North mouse model of lupus. Arthritis Rheum. 42:561-568.
18. Singh, J.N., Sabbadini, E., and Sehon, A.H. 1972. Cytotoxicity in graft-versus-host reaction. I. Role of donor and host spleen cells. J. Exp. Med. 136:39-48.
19. Morris, S.C., Cheek, R.L., Cohen, P.L., and Eisenberg, R.A. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171:503-517.
20. Garlisi, C.G., Pennline, K.J., Smith, S.R., Siegel, M.I., and Umland, S.P. 1993. Cytokine gene expression in mice undergoing chronic grafr-versus-host disease. Mol. Immunol. 30:669-677.
21. Gleichmann, E., van Elven, E.H., and Van Der Veen, P.J.W. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation. Preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12:152-159.
22. Bruijn, J.A., et al. 1988. Murine chronic graft-versus-host disease as a model for lupus nephritis. Am. J. Pathol. 130:639-641.
23. Bielschowsky, M., and D'Ath, E.F. 1971. The kidneys of NZB-B1, NZO-B1,NZC-B1 and NZY-B1 mice. J. Pathol. 103:97-105.
24. Kojima, H., et al. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity. 1:357-364.
25. Braun, M.Y., Lowin, B., Lars, F., Acha-Oreba, H., and Tschopp, J. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183:657-661.
26. Baker, M.B., Altman, N.H., Podack, E.R., and Levy, R.B. 1996. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice. J. Exp. Med. 183:2645-2656.
27. Baker, M.B., Riley, R.L. Podack, E.R., and Levy, R.B. 1997. Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function. Proc. Natl. Acad. Sci. USA, 94:1366-1371.
28. Moore, K.W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T.R. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
29. Burlingame, R.W., Rubin, R.L., Balderas, R.S., and Theofilopoulos, A.N. 1993. Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91:1687-1696.
30. Mohan, C., Adams, S., Stanik, V., and Datta, S.K. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367-1381.
31. Tsokos, G.C., and Balow, J.E. 1981. Cytotoxic responses to alloantigens in systemic lupus erythematosus. J. Clin. Immunol. 1:208-216.
32. Stohl, W. 1995. Impaired polyclonal T cell cytolytic activity: a possible risk factor for systemic lupus erythematosus. Arthritis Rheum. 38:506-516.
33. Tsokos, G.C. 1992. Lymphocyte abnormalities in human lupus. Clin. Immunol. Immunopathol. 63:7-9.
34. Georgescu, L. Vakkalanka, R.K., Elkon, K.B., and Crow, M.K. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100:2622-2633.
35. Nelson, J.L. 1998. Microchimerism and autoimmune disease. N. Engl. J Med. 338:1224-1225.
36. James, J.A., et al. 1997. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J. Clin. Invest. 100:3019-3026.
37. Horwitz, D.A., and Jacob, C.O. 1994. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications. Springer Semin. Immunopathol. 16:181-200.
38. Stohl, W., et al. 1997. Impaired nonrestricted cytolytic activity in systemic lupus erythematosus. Arthritis Rheum. 40:1130-1137.
39. Jacob, C.O., and McDevitt, H.O. 1988. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature. 331:356-358.